blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1874275

EP1874275 - COMPOSITONS AND METHODS FOR STABILIZING ACTIVE PHARMACEUTICAL INGREDIENTS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  16.12.2011
Database last updated on 15.06.2024
Most recent event   Tooltip16.12.2011Application deemed to be withdrawnpublished on 18.01.2012  [2012/03]
Applicant(s)For all designated states
McNeil-PPC, Inc.
One Johnson & Johnson Plaza New Brunswick
New Jersey 08933 / US
[N/P]
Former [2008/02]For all designated states
McNEIL-PPC, Inc.
One Johnson & Johnson Plaza New Brunswick
New Jersey 08933 / US
Inventor(s)01 / NICHOLS, William Michael, Pfizer Global R&D
201Ta bor Road
Morris Plains, NJ 07950 / US
 [2008/02]
Representative(s)Mercer, Christopher Paul, et al
Carpmaels & Ransford LLP
One Southampton Row
London
WC1B 5HA / GB
[N/P]
Former [2009/51]Mercer, Christopher Paul, et al
Carpmaels & Ransford 43-45 Bloomsbury Square
London WC1A 2RA / GB
Former [2008/02]Mercer, Christopher Paul, et al
Carpmaels & Ransford 43-45 Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date05810183.301.12.2005
[2008/02]
WO2005IB03723
Priority number, dateUS20040635450P13.12.2004         Original published format: US 635450 P
[2008/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2006064327
Date:22.06.2006
Language:EN
[2006/25]
Type: A1 Application with search report 
No.:EP1874275
Date:09.01.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 22.06.2006 takes the place of the publication of the European patent application.
[2008/02]
Search report(s)International search report - published on:EP22.06.2006
ClassificationIPC:A61K9/20, A61K9/28
[2008/02]
CPC:
A61K31/137 (EP,US); A61K9/20 (KR); A61K31/717 (EP,US);
A61K47/38 (EP,US); A61K9/2054 (EP,US); A61K9/28 (KR);
A61K9/2866 (EP,US); A61P11/02 (EP); A61P27/14 (EP);
A61P27/16 (EP); A61P43/00 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/02]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR STABILISIERUNG VON PHARMAZEUTISCHEN WIRKSTOFFEN[2008/02]
English:COMPOSITONS AND METHODS FOR STABILIZING ACTIVE PHARMACEUTICAL INGREDIENTS[2008/02]
French:COMPOSITIONS ET PROCEDES PERMETTANT DE STABILISER DES SUBSTANCES PHARMACEUTIQUES ACTIVES[2008/02]
Entry into regional phase06.07.2007National basic fee paid 
06.07.2007Designation fee(s) paid 
06.07.2007Examination fee paid 
Examination procedure16.01.2006Request for preliminary examination filed
International Preliminary Examining Authority: EP
06.07.2007Examination requested  [2008/02]
22.09.2009Despatch of a communication from the examining division (Time limit: M04)
29.01.2010Reply to a communication from the examining division
01.07.2011Application deemed to be withdrawn, date of legal effect  [2012/03]
11.08.2011Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2012/03]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  22.09.2009
Fees paidRenewal fee
06.07.2007Renewal fee patent year 03
31.03.2008Renewal fee patent year 04
11.12.2009Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.12.201006   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO9621429  (MENDELL CO INC EDWARD [US]) [X] 1-4,9-14,17,18,20 * claim - * * page 28, line 31 - page 30, line 26 * * example - *;
 [X]WO0174448  (MOVA PHARMACEUTICAL CORP [US], et al) [X] 1-4,12-14,17,18,20 * claim - * * example - * * page 4, line 19 - line 26 * * page 7, line 12 - line 14 * * page 9, line 20 - line 24 *;
 [X]WO2004000281  (LEK PHARMACEUTICALS [SI], et al) [X] 1-4,9,12-14,17,18,20 * claim - * * example - *;
 [X]WO2004050025  (FOREST LABORATORIES [US], et al) [X] 1,2,9-14,17,18,20 * claims 12-14 ** paragraphs [0042] , [0044] , [0048] , [0056] *;
 [X]WO2004091585  (SYNTHON BV [NL], et al) [X] 1-4,9-14,17,18,20 * claim - * * example - * * page 12, line 7 - page 14, line 3 *
by applicant   - H. LIEBERMAN; L. LACHMAN, Pharmaceutical Dosage Forms: Tablets, MARCEL DEKKER, (1980), vol. 1
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.